1 - 25 of 38 results for author:"Jove R." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Deng J., Liu Y., Lee H., Herrmann A., Zhang W., Zhang C., Shen S., Priceman S.J., Kujawski M., Pal S.K. et al. Cancer Cell 21:642-654(2012) · Mapped (22) |
| Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Lee H., Zhang P., Herrmann A., Yang C., Xin H., Wang Z., Hoon D.S., Forman S.J., Jove R., Riggs A.D. et al. Proc. Natl. Acad. Sci. U.S.A. 109:7765-7769(2012) · Mapped (7) |
| Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer. Haviland R., Eschrich S., Bloom G., Ma Y., Minton S., Jove R., Cress W.D. PLoS ONE 6:e24923-e24923(2011) · Mapped (8) |
| Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer. Kao W.H., Riker A.I., Kushwaha D.S., Ng K., Enkemann S.A., Jove R., Buettner R., Zinn P.O., Sanchez N.P., Villa J.L. et al. J. Invest. Dermatol. 131:2139-2142(2011) · Mapped (5) |
| STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Lee H., Deng J., Kujawski M., Yang C., Liu Y., Herrmann A., Kortylewski M., Horne D., Somlo G., Forman S. et al. Nat. Med. 16:1421-1428(2010) · Mapped (11) |
| STATs in cancer inflammation and immunity: a leading role for STAT3. Yu H., Pardoll D., Jove R. Nat. Rev. Cancer 9:798-809(2009) · Mapped (7) |
| Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3. Lin J., Buettner R., Yuan Y.C., Yip R., Horne D., Jove R., Vaidehi N. J. Mol. Graph. Model. 28:347-356(2009) · Mapped (11) |
| Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Lee H., Herrmann A., Deng J.H., Kujawski M., Niu G., Li Z., Forman S., Jove R., Pardoll D.M., Yu H. Cancer Cell 15:283-293(2009) · Mapped (14) |
| The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Hillion J., Dhara S., Sumter T.F., Mukherjee M., Di Cello F., Belton A., Turkson J., Jaganathan S., Cheng L., Ye Z. et al. Cancer Res. 68:10121-10127(2008) · Mapped (7) |
| miR-302b maintains "stemness" of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Lee N.S., Kim J.S., Cho W.J., Lee M.R., Steiner R., Gompers A., Ling D., Zhang J., Strom P., Behlke M. et al. Biochem. Biophys. Res. Commun. 377:434-440(2008) · Mapped (2) |
| Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Niu G., Briggs J., Deng J., Ma Y., Lee H., Kortylewski M., Kujawski M., Kay H., Cress W.D., Jove R. et al. Mol. Cancer Res. 6:1099-1105(2008) · Mapped (19) |
| RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase. Scuto A., Zhang H., Zhao H., Rivera M., Yeatman T.J., Jove R., Torres-Roca J.F. Cancer Res. 67:10317-10324(2007) · Mapped (9) |
| Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Siddiquee K., Zhang S., Guida W.C., Blaskovich M.A., Greedy B., Lawrence H.R., Yip M.L., Jove R., McLaughlin M.M., Lawrence N.J. et al. Proc. Natl. Acad. Sci. U.S.A. 104:7391-7396(2007) · Mapped (14) |
| Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10. Torres-Roca J.F., DeSilvio M., Mora L.B., Khor L.Y., Hammond E., Ahmad N., Jove R., Forman J., Lee R.J., Sandler H. et al. Urology 69:505-509(2007) · Mapped (2) |
| Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Anagnostopoulou A., Vultur A., Arulanandam R., Cao J., Turkson J., Jove R., Kim J.S., Glenn M., Hamilton A.D., Raptis L. Cancer Lett. 242:120-132(2006) · Mapped (20) |
| Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mule J., Kerr W.G. et al. Nat. Med. 11:1314-1321(2005) · Mapped (8) |
| Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. Park S., Kim D., Kaneko S., Szewczyk K.M., Nicosia S.V., Yu H., Jove R., Cheng J.Q. J. Biol. Chem. 280:38932-38941(2005) · Mapped (19) |
| Role of Stat3 in regulating p53 expression and function. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., Briggs J., Karras J., Cress W.D., Pardoll D. et al. Mol. Cell. Biol. 25:7432-7440(2005) · Mapped (50) |
| Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., Gritsko T., Turkson J., Kay H., Semenza G.L. et al. Oncogene 24:5552-5560(2005) · Mapped (16) |
| Expression and role of Foxa proteins in prostate cancer. Mirosevich J., Gao N., Gupta A., Shappell S.B., Jove R., Matusik R.J. Prostate 66:1013-1028(2006) · Mapped (6) |
| Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Vultur A., Arulanandam R., Turkson J., Niu G., Jove R., Raptis L. Mol. Biol. Cell 16:3832-3846(2005) · Mapped (22) |
| Stat3 regulates genes common to both wound healing and cancer. Dauer D.J., Ferraro B., Song L., Yu B., Mora L., Buettner R., Enkemann S., Jove R., Haura E.B. Oncogene 24:3397-3408(2005) · Mapped (7) |
| Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Sun J., Blaskovich M.A., Jove R., Livingston S.K., Coppola D., Sebti S.M. Oncogene 24:3236-3245(2005) · Mapped (14) |
| Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Vultur A., Cao J., Arulanandam R., Turkson J., Jove R., Greer P., Craig A., Elliott B., Raptis L. Oncogene 23:2600-2616(2004) · Mapped (7) |
| Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. Nefedova Y., Huang M., Kusmartsev S., Bhattacharya R., Cheng P., Salup R., Jove R., Gabrilovich D. J. Immunol. 172:464-474(2004) · Mapped (7) |